Renal cell carcinoma

By J. Hsieh, M. Purdue, S. Signoretti, Charles Swanton, L. Albiges, M. Schmidinger, D. Heng, J. Larkin, V. Ficarra. Nature Reviews Disease Primers, 2017

1,839 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/d8eaead21655cd24c24732e7e56221e13e9c3d55

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. W. Marston Linehan
2. Eric E. Schadt
3. A. Robles
4. Arul M. Chinnaiyan
5. Antonio Colaprico
6. Xi Chen
7. M. Wiznerowicz
8. A. Krek

In Molecular Biology

1. Alexey I. Nesvizhskii
2. Dmitry Avtonomov
3. Andy T. Kong
4. W. Marston Linehan
5. Eric E. Schadt
6. A. Robles
7. Bing Zhang
8. Arul M. Chinnaiyan

In Pulmonary and Respiratory Medicine

1. Arul M. Chinnaiyan

Citations in the corpus

• Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. (2019, background): “ccRCCs represent 80% of malignant renal tumours in adults, with the remaining 20% corresponding to several histological subtypes with different histological, molecular and cytogenetic profiles [7].”
• Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma (2019, background): “Clear cell renal cell carcinoma (ccRCC) is the predominant histology of renal cell carcinoma, representing 75% of all cases and the majority of cancerassociated deaths (Hsieh et al., 2017).”